DE112020003392T5 - Blutzuckerkontrollsystem - Google Patents
Blutzuckerkontrollsystem Download PDFInfo
- Publication number
- DE112020003392T5 DE112020003392T5 DE112020003392.9T DE112020003392T DE112020003392T5 DE 112020003392 T5 DE112020003392 T5 DE 112020003392T5 DE 112020003392 T DE112020003392 T DE 112020003392T DE 112020003392 T5 DE112020003392 T5 DE 112020003392T5
- Authority
- DE
- Germany
- Prior art keywords
- therapy
- subject
- insulin
- blood glucose
- control system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
- A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure the body parameters being measured at, or proximate to, the infusion site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/16—General characteristics of the apparatus with back-up system in case of failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or Bluetooth®
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Data Mining & Analysis (AREA)
Applications Claiming Priority (35)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962874972P | 2019-07-16 | 2019-07-16 | |
| US201962874959P | 2019-07-16 | 2019-07-16 | |
| US201962874977P | 2019-07-16 | 2019-07-16 | |
| US201962874975P | 2019-07-16 | 2019-07-16 | |
| US201962874964P | 2019-07-16 | 2019-07-16 | |
| US201962874950P | 2019-07-16 | 2019-07-16 | |
| US201962874954P | 2019-07-16 | 2019-07-16 | |
| US201962874934P | 2019-07-16 | 2019-07-16 | |
| US201962874928P | 2019-07-16 | 2019-07-16 | |
| US201962874968P | 2019-07-16 | 2019-07-16 | |
| US62/874,972 | 2019-07-16 | ||
| US62/874,959 | 2019-07-16 | ||
| US62/874,975 | 2019-07-16 | ||
| US62/874,950 | 2019-07-16 | ||
| US62/874,934 | 2019-07-16 | ||
| US62/874,964 | 2019-07-16 | ||
| US62/874,977 | 2019-07-16 | ||
| US62/874,928 | 2019-07-16 | ||
| US62/874,954 | 2019-07-16 | ||
| US62/874,968 | 2019-07-16 | ||
| US201962910970P | 2019-10-04 | 2019-10-04 | |
| US201962911143P | 2019-10-04 | 2019-10-04 | |
| US201962911017P | 2019-10-04 | 2019-10-04 | |
| US62/910,970 | 2019-10-04 | ||
| US62/911,017 | 2019-10-04 | ||
| US62/911,143 | 2019-10-04 | ||
| US202062987842P | 2020-03-10 | 2020-03-10 | |
| US62/987,842 | 2020-03-10 | ||
| US202063037472P | 2020-06-10 | 2020-06-10 | |
| US63/037,472 | 2020-06-10 | ||
| USPCT/US2020/042198 | 2020-07-15 | ||
| PCT/US2020/042198 WO2021011699A1 (en) | 2019-07-16 | 2020-07-15 | Ambulatory device and components thereof |
| PCT/US2020/042195 WO2021011697A1 (en) | 2019-07-16 | 2020-07-15 | Blood glucose control system |
| USPCT/US2020/042195 | 2020-07-15 | ||
| PCT/US2020/042269 WO2021011738A1 (en) | 2019-07-16 | 2020-07-16 | Blood glucose control system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE112020003392T5 true DE112020003392T5 (de) | 2022-05-19 |
Family
ID=74211371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE112020003392.9T Pending DE112020003392T5 (de) | 2019-07-16 | 2020-07-16 | Blutzuckerkontrollsystem |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US11040141B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3998943A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7682453B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114760918A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020314831B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3252649A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE112020003392T5 (cg-RX-API-DMAC7.html) |
| IL (1) | IL289857A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022000670A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021011738A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7972296B2 (en) | 2007-10-10 | 2011-07-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| WO2014172467A1 (en) | 2013-04-16 | 2014-10-23 | Smartloop Llc | Discretionary insulin delivery systems and methods |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| CA2977053C (en) | 2015-02-18 | 2023-08-01 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
| EP3319511B1 (en) | 2015-08-07 | 2021-10-06 | Trustees of Boston University | Glucose control system with automatic adaptation of glucose target |
| EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
| EP4545005A3 (en) | 2016-01-14 | 2025-07-02 | Insulet Corporation | Adjusting insulin delivery rates |
| HK1256995A1 (zh) | 2016-01-14 | 2019-10-11 | Bigfoot Biomedical, Inc. | 药物输送设备、系统和方法中的阻塞解决方案 |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| US20170348479A1 (en) | 2016-06-03 | 2017-12-07 | Bryan Choate | Adhesive system for drug delivery device |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| AU2017376111B2 (en) | 2016-12-12 | 2023-02-02 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
| EP4708311A3 (en) | 2017-01-13 | 2026-05-20 | Insulet Corporation | METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10583250B2 (en) | 2017-01-13 | 2020-03-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP4708310A3 (en) | 2017-01-13 | 2026-05-06 | Insulet Corporation | Insulin delivery methods, systems and devices |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US12653426B2 (en) | 2017-07-13 | 2026-06-16 | Bigfoot Biomedical, Inc. | Multi-scale display of blood glucose information |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| US12562251B1 (en) | 2018-05-09 | 2026-02-24 | Bigfoot Biomedical, Inc. | Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices |
| JP7307147B2 (ja) | 2018-07-17 | 2023-07-11 | インスレット コーポレイション | 薬剤送出ポンプ用の低い起動力を有するバルブ |
| AU2019347755B2 (en) | 2018-09-28 | 2023-02-02 | Insulet Corporation | Activity mode for artificial pancreas system |
| WO2020077223A1 (en) | 2018-10-11 | 2020-04-16 | Insulet Corporation | Event detection for drug delivery system |
| US12357751B2 (en) | 2018-11-08 | 2025-07-15 | Tandem Diabetes Care, Inc. | Linear insertion device with rotational drive |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| MX2022000670A (es) | 2019-07-16 | 2022-05-20 | Beta Bionics Inc | Sistema de control de glucosa en sangre. |
| JP7657428B2 (ja) | 2019-07-16 | 2025-04-07 | ベータ バイオニクス,インコーポレイテッド | 血糖制御システム |
| US11957876B2 (en) | 2019-07-16 | 2024-04-16 | Beta Bionics, Inc. | Glucose control system with automated backup therapy protocol generation |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| MX2022003961A (es) * | 2019-10-04 | 2022-07-21 | Beta Bionics Inc | Sistema de control de glucosa en sangre. |
| EP4354455B1 (en) | 2019-12-06 | 2025-10-29 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| WO2021141941A1 (en) | 2020-01-06 | 2021-07-15 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| WO2022126080A1 (en) | 2020-12-07 | 2022-06-16 | Beta Bionics, Inc. | Medicament pumps and control systems for managing glucose control therapy data of a subject |
| WO2021158580A1 (en) | 2020-02-03 | 2021-08-12 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| US11690955B2 (en) * | 2020-04-23 | 2023-07-04 | Medtronic Minimed, Inc. | Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system |
| US12575797B2 (en) | 2020-06-11 | 2026-03-17 | Willow Laboratories, Inc. | Blood glucose disease management system |
| US12121700B2 (en) | 2020-07-22 | 2024-10-22 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| EP4204040A1 (en) | 2020-08-27 | 2023-07-05 | Insulet Corporation | Wearable micro-dosing drug delivery device |
| EP4204066A4 (en) | 2020-08-28 | 2024-11-13 | Tandem Diabetes Care, Inc. | INSULIN INFUSION SET |
| US20220062546A1 (en) * | 2020-08-31 | 2022-03-03 | Insulet Corporation | Adjusting settings to different degrees of aggressiveness in an automated insulin delivery system based on quality of blood glucose level control by a user |
| US12569619B2 (en) | 2020-09-21 | 2026-03-10 | Insulet Corporation | Techniques for determining automated insulin delivery dosages |
| US12115351B2 (en) | 2020-09-30 | 2024-10-15 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| EP4696344A3 (en) | 2020-09-30 | 2026-04-15 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| US12491310B2 (en) | 2021-01-12 | 2025-12-09 | Insulet Corporation | Wearable drug delivery device with removal element |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| EP4285376A1 (en) | 2021-01-29 | 2023-12-06 | Insulet Corporation | Techniques and devices that adapt basal profiles for drug delivery applications |
| USD1059372S1 (en) * | 2021-12-03 | 2025-01-28 | Abbott Diabetes Care Inc. | Display screen or portion thereof with graphical user interface |
| US12702755B1 (en) * | 2021-02-12 | 2026-08-11 | Willow Laboratories, Inc. | Model predictive control in a closed loop control system for continuous glucose monitoring |
| US12636435B2 (en) | 2021-02-26 | 2026-05-26 | Insulet Corporation | Techniques for optimizing usage of an automatic drug delivery system |
| US20220287633A1 (en) * | 2021-03-09 | 2022-09-15 | Insulet Corporation | Opportunistic retrieval of analyte value to improve automatic drug control accuracy |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| WO2022192482A1 (en) | 2021-03-10 | 2022-09-15 | Insulet Corporation | A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| WO2022198128A1 (en) * | 2021-03-19 | 2022-09-22 | Horton William B | System and method for identifying and predicting hypoglycemia risk |
| US12465686B2 (en) | 2021-03-25 | 2025-11-11 | Beta Bionics, Inc. | Emergency medicament dose control |
| WO2022204705A1 (en) * | 2021-03-25 | 2022-09-29 | Beta Bionics, Inc. | Emergency medicament dose control |
| USD1127405S1 (en) | 2021-03-25 | 2026-05-26 | Beta Bionics, Inc. | Clip for bionic pancreas infusion pump cases |
| US12592306B2 (en) | 2021-04-28 | 2026-03-31 | Insulet Corporation | Devices and methods for initialization of drug delivery devices using measured analyte sensor information |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| EP4101482A1 (en) | 2021-06-07 | 2022-12-14 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US20220401640A1 (en) * | 2021-06-17 | 2022-12-22 | Icu Medical, Inc. | Intravenous infusion pumps with system and pharmacodynamic model adjustment for display and operation |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| USD1013704S1 (en) * | 2021-07-09 | 2024-02-06 | The Regents Of The University Of Colorado, A Body Corporate | Display screen or portion thereof with graphical user interface |
| USD1014518S1 (en) * | 2021-07-09 | 2024-02-13 | The Regents Of The University Of Colorado, A Body Corporate | Display screen or portion thereof with graphical user interface |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| US12653949B2 (en) | 2021-07-29 | 2026-06-16 | Insulet Corporation | Adaptation of medicament delivery in response to user stress load |
| CN113784292B (zh) * | 2021-08-24 | 2022-07-26 | 同济大学 | 一种基于手机信令数据的城市疫情风险评估方法 |
| EP4409581A1 (en) | 2021-09-27 | 2024-08-07 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| USD1112327S1 (en) * | 2021-11-03 | 2026-02-10 | Alcon Inc. | Display screen or portion thereof with a graphical user interface |
| USD1112328S1 (en) | 2021-11-03 | 2026-02-10 | Alcon Inc. | Display screen or portion thereof with a graphical user interface |
| WO2023102010A1 (en) * | 2021-11-30 | 2023-06-08 | Tandem Diabetes Care, Inc. | System and method of modifying user profile in automated insulin delivery |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| WO2023150737A1 (en) | 2022-02-07 | 2023-08-10 | Insulet Corporation | Techniques for determining medication correction factors in automatic medication delivery systems |
| EP4243030A1 (en) | 2022-03-09 | 2023-09-13 | Insulet Corporation | Adjusting medicament delivery parameters in an open loop medicament delivery mode |
| WO2023173167A1 (en) * | 2022-03-15 | 2023-09-21 | Eveda Ip Pty Ltd | A computer system for diagnostic assessments and a method thereof |
| EP4511843A1 (en) | 2022-04-21 | 2025-02-26 | Insulet Corporation | Insulin adaptation and safety monitoring for sick day management |
| CN114903648B (zh) * | 2022-05-09 | 2022-11-22 | 北京理工大学 | 一种基于eso和模型预测控制的双激素人工胰腺控制器 |
| US20230381414A1 (en) * | 2022-05-27 | 2023-11-30 | Insulet Corporation | Assessment of past insulin delivery outcomes to automatically tune mda systems |
| US20230414872A1 (en) * | 2022-06-24 | 2023-12-28 | Peking University | Drug injection device based on electrochemical reaction and fabrication method for drug injection pump |
| USD1117222S1 (en) * | 2022-08-11 | 2026-03-10 | Healthpartners Institute | Display screen with graphical user interface |
| WO2024049849A1 (en) * | 2022-08-29 | 2024-03-07 | Carefusion 303, Inc. | Management of medication delivery failures |
| KR20250129777A (ko) | 2023-01-06 | 2025-08-29 | 인슐렛 코포레이션 | 후속 자동 안전 제약 완화를 갖는 자동으로 또는 수동으로 개시되는 음식 볼러스 전달 |
| US20240374813A1 (en) * | 2023-05-12 | 2024-11-14 | Insulet Corporation | Methods to demonstrate progress towards full adaptation and to present potential improvements through behavioral changes |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080208113A1 (en) | 2005-05-13 | 2008-08-28 | Trustees Of Boston University | Fully Automated Control System for Type I Diabetes |
| WO2012058694A2 (en) | 2010-10-31 | 2012-05-03 | Trustees Of Boston University | Blood glucose control system |
| WO2015116524A1 (en) | 2014-01-31 | 2015-08-06 | Trustees Of Boston University | Offline glucose control based on preceding periods |
| WO2017027459A1 (en) | 2015-08-07 | 2017-02-16 | Trustees Of Boston University | Glucose control system with automatic adaptation of glucose target |
Family Cites Families (141)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6241704B1 (en) * | 1901-11-22 | 2001-06-05 | Sims Deltec, Inc. | Drug pump systems and methods |
| US4280494A (en) | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
| US4464170A (en) | 1982-09-29 | 1984-08-07 | Miles Laboratories, Inc. | Blood glucose control apparatus and method |
| WO1989001794A1 (en) | 1987-08-28 | 1989-03-09 | Regents Of The University Of Minnesota | Metabolic sensor for a drug delivery system |
| US5665065A (en) | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
| US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| US6669663B1 (en) | 1999-04-30 | 2003-12-30 | Medtronic, Inc. | Closed loop medicament pump |
| US6925393B1 (en) | 1999-11-18 | 2005-08-02 | Roche Diagnostics Gmbh | System for the extrapolation of glucose concentration |
| DE10006044A1 (de) | 2000-02-10 | 2001-08-16 | Roche Diagnostics Gmbh | Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons |
| US6572542B1 (en) | 2000-03-03 | 2003-06-03 | Medtronic, Inc. | System and method for monitoring and controlling the glycemic state of a patient |
| US7460130B2 (en) | 2000-09-26 | 2008-12-02 | Advantage 3D Llc | Method and system for generation, storage and distribution of omni-directional object views |
| US20030073609A1 (en) | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
| US6544212B2 (en) | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
| US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
| US6852104B2 (en) | 2002-02-28 | 2005-02-08 | Smiths Medical Md, Inc. | Programmable insulin pump |
| US20080172026A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a suspension bolus |
| GB0206792D0 (en) | 2002-03-22 | 2002-05-01 | Leuven K U Res & Dev | Normoglycemia |
| US20040010207A1 (en) | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
| CN1859943B (zh) | 2002-10-11 | 2010-09-29 | 贝克顿·迪金森公司 | 用于控制患者体内葡萄糖的浓度的系统 |
| US7655618B2 (en) | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| US9872890B2 (en) | 2003-03-19 | 2018-01-23 | Paul C. Davidson | Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| US20050182366A1 (en) | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
| US20040253736A1 (en) | 2003-06-06 | 2004-12-16 | Phil Stout | Analytical device with prediction module and related methods |
| US7729306B2 (en) | 2003-07-24 | 2010-06-01 | Qualcomm Incorporated | Method and apparatus for providing a service threshold indicator in a wireless communication system |
| US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
| DE102004011135A1 (de) | 2004-03-08 | 2005-09-29 | Disetronic Licensing Ag | Verfahren und Vorrichtung zum Berechnen einer Bolusmenge |
| US7651845B2 (en) | 2004-05-13 | 2010-01-26 | The Regents Of The University Of California | Method and apparatus for glucose control and insulin dosing for diabetics |
| US7727147B1 (en) | 2004-05-14 | 2010-06-01 | Flint Hills Scientific Llc | Method and system for implantable glucose monitoring and control of a glycemic state of a subject |
| US20060272652A1 (en) | 2005-06-03 | 2006-12-07 | Medtronic Minimed, Inc. | Virtual patient software system for educating and treating individuals with diabetes |
| US20070033074A1 (en) * | 2005-06-03 | 2007-02-08 | Medtronic Minimed, Inc. | Therapy management system |
| US20060276771A1 (en) | 2005-06-06 | 2006-12-07 | Galley Paul J | System and method providing for user intervention in a diabetes control arrangement |
| US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
| CN100446724C (zh) | 2005-11-28 | 2008-12-31 | 中国科学院电子学研究所 | 用于闭环胰岛素注射的无创血糖仪 |
| US9392969B2 (en) * | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
| US20070255126A1 (en) | 2006-04-28 | 2007-11-01 | Moberg Sheldon B | Data communication in networked fluid infusion systems |
| JP4918285B2 (ja) | 2006-05-24 | 2012-04-18 | シスメックス株式会社 | 生体器官の機能のシミュレーションシステム及びそのプログラム |
| US8548544B2 (en) | 2006-06-19 | 2013-10-01 | Dose Safety | System, method and article for controlling the dispensing of insulin |
| US20110054391A1 (en) | 2006-07-28 | 2011-03-03 | Ward W Kenneth | Analyte sensing and response system |
| WO2008057384A2 (en) | 2006-11-02 | 2008-05-15 | The University Of North Carolina At Chapel Hill | Methods and systems for determining an intravenous insulin infusion rate |
| US7654127B2 (en) | 2006-12-21 | 2010-02-02 | Lifescan, Inc. | Malfunction detection in infusion pumps |
| US7946985B2 (en) * | 2006-12-29 | 2011-05-24 | Medtronic Minimed, Inc. | Method and system for providing sensor redundancy |
| US10154804B2 (en) | 2007-01-31 | 2018-12-18 | Medtronic Minimed, Inc. | Model predictive method and system for controlling and supervising insulin infusion |
| EP2139540A1 (en) | 2007-03-19 | 2010-01-06 | Medingo Ltd. | User interface for selecting bolus doses in a drug delivery device |
| EP1983456B1 (de) | 2007-04-19 | 2013-08-14 | F.Hoffmann-La Roche Ag | Verfahren zum Einstellen eines Basalratenprofils für eine Insulinpumpe |
| US20080269714A1 (en) | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| US20100145262A1 (en) | 2007-05-03 | 2010-06-10 | Novo Nordisk A/S | Safety system for insulin delivery advisory algorithms |
| US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
| WO2009013637A2 (en) | 2007-06-20 | 2009-01-29 | Medingo Headquarters | Method and device for assessing carbohydrate-to-insulin ratio |
| EP2166946B1 (en) | 2007-06-21 | 2019-11-20 | University Of Virginia Patent Foundation | Lqg artificial pancreas control system and related method |
| JP2010531707A (ja) | 2007-06-25 | 2010-09-30 | メディンゴ・リミテッド | 適合された基礎インスリン送達システム |
| EP2171630A1 (en) | 2007-06-27 | 2010-04-07 | F. Hoffmann-Roche AG | System and method for developing patient specific therapies based on modeling of patient physiology |
| US10231077B2 (en) | 2007-07-03 | 2019-03-12 | Eingot Llc | Records access and management |
| EP2164387A4 (en) | 2007-07-09 | 2011-09-07 | Univ Virginia Patent Found | METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR THE ASSESSMENT OF INSULIN SENSITIVITY, INSULIN / GLUCOSE RATIO AND INSULIN CORRECTION FACTORS IN DIABETES FROM SELF-MONITORING DATA |
| US20090036753A1 (en) | 2007-07-31 | 2009-02-05 | King Allen B | Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas |
| US7717903B2 (en) | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
| US8032226B2 (en) * | 2007-09-07 | 2011-10-04 | Asante Solutions, Inc. | User profile backup system for an infusion pump device |
| WO2009031636A1 (ja) | 2007-09-07 | 2009-03-12 | Terumo Kabushiki Kaisha | 血糖値測定装置 |
| US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
| WO2009059187A1 (en) | 2007-11-02 | 2009-05-07 | University Of Virginia Patent Foundation | Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing |
| US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
| US20090177154A1 (en) | 2008-01-08 | 2009-07-09 | Michael Blomquist | Insulin pump with convenience features |
| US20090177142A1 (en) | 2008-01-09 | 2009-07-09 | Smiths Medical Md, Inc | Insulin pump with add-on modules |
| US9341614B2 (en) | 2008-04-04 | 2016-05-17 | Hygieia, Inc. | Apparatus and methods for taking blood glucose measurements and recommending insulin doses |
| ES2670793T3 (es) | 2008-04-04 | 2018-06-01 | Hygieia, Inc. | Aparato para optimizar un régimen posológico de insulina para un paciente |
| CN201186082Y (zh) | 2008-05-05 | 2009-01-28 | 王安宇 | 胰岛素、葡萄糖智能输入装置 |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
| US8527208B2 (en) | 2008-11-17 | 2013-09-03 | Roche Diagnostics International Ag | Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof |
| JP5657559B2 (ja) | 2008-11-26 | 2015-01-21 | ユニバーシティ オブ ヴァージニア パテント ファウンデーション | 糖尿病における血糖変動を追跡記録するための方法、システム及びコンピュータ・プログラム |
| CN102369030A (zh) | 2009-02-04 | 2012-03-07 | 赛诺菲-安万特德国有限公司 | 用于基于血糖应答信息血糖控制的医疗系统和方法 |
| CN105268051B (zh) | 2009-02-04 | 2019-04-19 | 赛诺菲-安万特德国有限公司 | 用于提供用于血糖控制的信息的医疗系统和方法 |
| WO2010099313A1 (en) | 2009-02-25 | 2010-09-02 | University Of Virginia Patent Foundation | Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery |
| US20120123234A1 (en) | 2009-02-26 | 2012-05-17 | Eran Atlas | Method and system for automatic monitoring of diabetes related treatments |
| US20100256466A1 (en) | 2009-04-02 | 2010-10-07 | Avraham Shekalim | Metabolite Management System |
| EP4325520A3 (en) | 2009-05-29 | 2024-05-15 | University Of Virginia Patent Foundation | System coordinator and modular architecture for open-loop and closed-loop control of diabetes |
| US8798934B2 (en) | 2009-07-23 | 2014-08-05 | Abbott Diabetes Care Inc. | Real time management of data relating to physiological control of glucose levels |
| WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
| US20120245556A1 (en) | 2009-09-01 | 2012-09-27 | University Of Virginia Patent Foundation | System, Method and Computer Program Product For Adjustment of Insulin Delivery in Diabetes Using Nominal Open-Loop Profiles |
| CN107252508A (zh) | 2009-09-18 | 2017-10-17 | F·霍夫曼-拉罗氏股份公司 | 用于根据用户参数对单次剂量进行量化的装置、系统和方法 |
| EP2483824B1 (en) | 2009-09-30 | 2017-08-16 | DreaMed Diabetes Ltd | Monitoring device for management of insulin delivery |
| US8690820B2 (en) | 2009-10-06 | 2014-04-08 | Illinois Institute Of Technology | Automatic insulin pumps using recursive multivariable models and adaptive control algorithms |
| US20110098548A1 (en) * | 2009-10-22 | 2011-04-28 | Abbott Diabetes Care Inc. | Methods for modeling insulin therapy requirements |
| US20110098638A1 (en) | 2009-10-27 | 2011-04-28 | Medtronic Minimed, Inc. | Sensor-Augmented Medication Infusion System |
| EP2496289A4 (en) | 2009-11-04 | 2013-06-26 | Aimedics Pty Ltd | SYSTEM AND METHOD FOR INTEGRATING HYPOGLY KEMIA ALARMS THROUGH COLLECTED DATA IN GLYCOME CONTROL SYSTEMS WITH CLOSED CONTROL CIRCUITS |
| US8762070B2 (en) | 2010-02-11 | 2014-06-24 | Regents Of The University Of California | Systems, devices and methods to deliver biological factors or drugs to a subject |
| US8579879B2 (en) * | 2010-02-19 | 2013-11-12 | Medtronic Minimed, Inc. | Closed-loop glucose control startup |
| WO2011119832A1 (en) | 2010-03-26 | 2011-09-29 | University Of Virginia Patent Foundation | Method, system, and computer program product for improving the accuracy of glucose sensors using insulin delivery observation in diabetes |
| JP2012024521A (ja) | 2010-07-28 | 2012-02-09 | Seiko Epson Corp | 血糖値予測装置 |
| US9445757B2 (en) | 2010-12-29 | 2016-09-20 | Medtronic Minimed, Inc. | Glycemic health metric determination and application |
| WO2012178134A2 (en) | 2011-06-23 | 2012-12-27 | University Of Virginia Patent Foundation | Unified platform for monitoring and control of blood glucose levels in diabetic patients |
| WO2013019852A2 (en) | 2011-08-01 | 2013-02-07 | Tandem Diabetes Care, Inc. | Therapy management system |
| GB2493712B (en) | 2011-08-12 | 2014-07-02 | Gene Onyx Ltd | Insulin pump |
| US8745298B2 (en) | 2011-10-24 | 2014-06-03 | Roche Diagnostics Operations, Inc. | Interoperability enhancement that supports connectivity of applications on a medical device |
| US10694983B2 (en) | 2012-01-19 | 2020-06-30 | Medtronic Minimed, Inc. | Method and/or system for assessing a patient's glycemic response |
| US9883834B2 (en) | 2012-04-16 | 2018-02-06 | Farid Amirouche | Medication delivery device with multi-reservoir cartridge system and related methods of use |
| US9238100B2 (en) | 2012-06-07 | 2016-01-19 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
| US9662445B2 (en) | 2012-08-30 | 2017-05-30 | Medtronic Minimed, Inc. | Regulating entry into a closed-loop operating mode of an insulin infusion system |
| US9901677B2 (en) | 2012-10-16 | 2018-02-27 | Bigfoot Biomedical, Inc. | Infusion pump system and methods |
| US9486578B2 (en) | 2012-12-07 | 2016-11-08 | Animas Corporation | Method and system for tuning a closed-loop controller for an artificial pancreas |
| US9907909B2 (en) | 2012-12-20 | 2018-03-06 | Animas Corporation | Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas |
| CA3123172C (en) | 2012-12-21 | 2026-05-19 | Deka Products Limited Partnership | System and apparatus for electronic patient care |
| US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
| EP2943150B1 (en) | 2013-01-14 | 2018-12-05 | The Regents of The University of California | Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications |
| US9492608B2 (en) | 2013-03-15 | 2016-11-15 | Tandem Diabetes Care, Inc. | Method and device utilizing insulin delivery protocols |
| US10016561B2 (en) | 2013-03-15 | 2018-07-10 | Tandem Diabetes Care, Inc. | Clinical variable determination |
| US9517306B2 (en) | 2013-03-15 | 2016-12-13 | Animas Corporation | Method and system for closed-loop control of an artificial pancreas |
| EP3030140B1 (en) * | 2013-08-05 | 2019-06-19 | Hygieia, Inc. | Systems and devices for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
| EP2851823A1 (en) | 2013-09-20 | 2015-03-25 | Sanofi-Aventis Deutschland GmbH | Data management unit for supporting health control |
| US10569015B2 (en) | 2013-12-02 | 2020-02-25 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| US10925536B2 (en) | 2014-01-03 | 2021-02-23 | University Of Virginia Patent Foundation | Systems of centralized data exchange for monitoring and control of blood glucose |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| US9399096B2 (en) | 2014-02-06 | 2016-07-26 | Medtronic Minimed, Inc. | Automatic closed-loop control adjustments and infusion systems incorporating same |
| GB201407896D0 (en) * | 2014-05-05 | 2014-06-18 | Joanneum Res Forschungsgmbh | Insulin dosage proposal system |
| EP3148419A4 (en) | 2014-05-27 | 2018-01-24 | ResMed Limited | Remote respiratory therapy device management |
| CN106456870B (zh) | 2014-06-10 | 2020-01-21 | 比格福特生物医学有限公司 | 胰岛素递送系统和方法 |
| US9629901B2 (en) | 2014-07-01 | 2017-04-25 | Bigfoot Biomedical, Inc. | Glucagon administration system and methods |
| CN104667368B (zh) | 2015-03-06 | 2017-08-15 | 上海交通大学 | 控制与计算分离的胰岛素泵动态控制实现方法 |
| CN104667379B (zh) | 2015-03-06 | 2017-08-15 | 上海交通大学 | 动态闭环控制的胰岛素泵 |
| AU2015388462A1 (en) | 2015-03-24 | 2017-09-21 | Ares Trading S.A. | Patient care system |
| EP3337402B1 (en) * | 2015-08-20 | 2026-01-07 | Glytec, LLC | Diabetes management therapy advisor |
| US10569016B2 (en) | 2015-12-29 | 2020-02-25 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
| HK1257215A1 (zh) * | 2016-01-05 | 2019-10-18 | Bigfoot Biomedical, Inc. | 操作多模式药物输送系统 |
| EP4545005A3 (en) | 2016-01-14 | 2025-07-02 | Insulet Corporation | Adjusting insulin delivery rates |
| US9980140B1 (en) | 2016-02-11 | 2018-05-22 | Bigfoot Biomedical, Inc. | Secure communication architecture for medical devices |
| US10426342B2 (en) | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
| US20200254240A1 (en) * | 2016-05-15 | 2020-08-13 | Biolinq, Inc. | Devices and Methods For The Incorporation Of A Microneedle Array Analyte-Selective Sensor Into An Infusion Set, Patch Pump, Or Automated Therapeutic Delivery System |
| EP3485409B1 (en) | 2016-07-15 | 2024-11-06 | Universität Bern | Estimation of insulin based on reinforcement learning |
| US10994077B2 (en) | 2016-07-21 | 2021-05-04 | Tandem Diabetes Care, Inc. | Enhanced confirmations for touchscreen infusion pump |
| US10896245B2 (en) | 2016-08-29 | 2021-01-19 | Bigfoot Biomedical, Inc. | Network topology for insulin pump systems |
| US10881793B2 (en) * | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP4708311A3 (en) | 2017-01-13 | 2026-05-20 | Insulet Corporation | METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION |
| WO2018183076A1 (en) | 2017-03-29 | 2018-10-04 | Becton, Dickinson And Company | System and method for operating controller of delivery device having swipe and tap to confirm feature |
| US11147920B2 (en) | 2017-04-18 | 2021-10-19 | Lifescan Ip Holdings, Llc | Diabetes management system with automatic basal and manual bolus insulin control |
| WO2019089324A1 (en) | 2017-10-30 | 2019-05-09 | Dexcom, Inc. | Diabetes management partner interface for wireless communication of analyte data |
| US11424027B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Method for operating surgical instrument systems |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| US11957876B2 (en) | 2019-07-16 | 2024-04-16 | Beta Bionics, Inc. | Glucose control system with automated backup therapy protocol generation |
| MX2022000670A (es) | 2019-07-16 | 2022-05-20 | Beta Bionics Inc | Sistema de control de glucosa en sangre. |
| JP7657428B2 (ja) | 2019-07-16 | 2025-04-07 | ベータ バイオニクス,インコーポレイテッド | 血糖制御システム |
| US20210283332A1 (en) | 2020-03-10 | 2021-09-16 | Trustees Of Boston University | Integrated user-defined input into a closed-loop glucose control system |
-
2020
- 2020-07-16 MX MX2022000670A patent/MX2022000670A/es unknown
- 2020-07-16 CA CA3252649A patent/CA3252649A1/en active Pending
- 2020-07-16 CN CN202080064387.0A patent/CN114760918A/zh active Pending
- 2020-07-16 DE DE112020003392.9T patent/DE112020003392T5/de active Pending
- 2020-07-16 EP EP20839937.8A patent/EP3998943A4/en not_active Withdrawn
- 2020-07-16 WO PCT/US2020/042269 patent/WO2021011738A1/en not_active Ceased
- 2020-07-16 AU AU2020314831A patent/AU2020314831B2/en active Active
- 2020-07-16 JP JP2022502591A patent/JP7682453B2/ja active Active
- 2020-07-16 CA CA3146965A patent/CA3146965C/en active Active
- 2020-10-02 US US17/062,022 patent/US11040141B2/en active Active
- 2020-10-02 US US17/061,917 patent/US10940267B2/en active Active
- 2020-10-02 US US17/061,927 patent/US11116902B2/en active Active
- 2020-10-02 US US17/061,990 patent/US10960137B2/en active Active
-
2021
- 2021-03-05 US US17/194,030 patent/US11744947B2/en active Active
- 2021-03-26 US US17/213,929 patent/US11766518B2/en active Active
- 2021-06-16 US US17/349,219 patent/US11679201B2/en active Active
-
2022
- 2022-01-15 IL IL289857A patent/IL289857A/en unknown
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080208113A1 (en) | 2005-05-13 | 2008-08-28 | Trustees Of Boston University | Fully Automated Control System for Type I Diabetes |
| US7806854B2 (en) | 2005-05-13 | 2010-10-05 | Trustees Of Boston University | Fully automated control system for type 1 diabetes |
| WO2012058694A2 (en) | 2010-10-31 | 2012-05-03 | Trustees Of Boston University | Blood glucose control system |
| US20130245547A1 (en) | 2010-10-31 | 2013-09-19 | Trustees Of Boston University | Blood glucose control system |
| US9833570B2 (en) | 2010-10-31 | 2017-12-05 | Trustees Of Boston University | Blood glucose control system |
| WO2015116524A1 (en) | 2014-01-31 | 2015-08-06 | Trustees Of Boston University | Offline glucose control based on preceding periods |
| US20160331898A1 (en) | 2014-01-31 | 2016-11-17 | Trustees Of Boston University | Glucose level control system with offline control based on preceding periods of online control |
| US10543313B2 (en) | 2014-01-31 | 2020-01-28 | Trustees Of Boston University | Glucose level control system with offline control based on preceding periods of online control |
| WO2017027459A1 (en) | 2015-08-07 | 2017-02-16 | Trustees Of Boston University | Glucose control system with automatic adaptation of glucose target |
| US20180220942A1 (en) | 2015-08-07 | 2018-08-09 | Trustees Of Boston University | Glucose control system with automatic adaptation of glucose target |
Also Published As
| Publication number | Publication date |
|---|---|
| US11766518B2 (en) | 2023-09-26 |
| US20210016005A1 (en) | 2021-01-21 |
| US11040141B2 (en) | 2021-06-22 |
| JP2022541491A (ja) | 2022-09-26 |
| US10940267B2 (en) | 2021-03-09 |
| EP3998943A4 (en) | 2023-09-06 |
| CN114760918A (zh) | 2022-07-15 |
| US11744947B2 (en) | 2023-09-05 |
| WO2021011738A1 (en) | 2021-01-21 |
| US20220062547A1 (en) | 2022-03-03 |
| JP7682453B2 (ja) | 2025-05-26 |
| CA3146965A1 (en) | 2021-02-21 |
| CA3252649A1 (en) | 2026-06-21 |
| IL289857A (en) | 2022-03-01 |
| AU2020314831A1 (en) | 2022-02-24 |
| US20210402090A1 (en) | 2021-12-30 |
| US20210016006A1 (en) | 2021-01-21 |
| MX2022000670A (es) | 2022-05-20 |
| US10960137B2 (en) | 2021-03-30 |
| US20210016003A1 (en) | 2021-01-21 |
| US11679201B2 (en) | 2023-06-20 |
| AU2020314831B2 (en) | 2026-07-09 |
| EP3998943A1 (en) | 2022-05-25 |
| US20210299352A1 (en) | 2021-09-30 |
| US20210016004A1 (en) | 2021-01-21 |
| US11116902B2 (en) | 2021-09-14 |
| CA3146965C (en) | 2025-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7682453B2 (ja) | 血糖制御システム | |
| DE112020004780T5 (de) | Blutzuckerkontrollsystem | |
| US11957876B2 (en) | Glucose control system with automated backup therapy protocol generation | |
| CN115052516B (zh) | 决策支持和治疗管理系统 | |
| EP1722841B1 (de) | Vorrichtung zum berechnen einer bolusmenge | |
| US20210193285A1 (en) | A system and method for use in disease treatment management | |
| DE60315443T2 (de) | Patientenkontrollierte aktivierung von implantierbaren vorrichtungen zur verabreichung von arzneien | |
| Berget et al. | Clinical implementation of the Omnipod 5 automated insulin delivery system: key considerations for training and onboarding people with diabetes | |
| US10456090B2 (en) | Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems | |
| WO2022235714A1 (en) | Glucose level control systems and methods | |
| US20230405224A1 (en) | Autonomous dose determination for pen delivery of medicament | |
| Feliziani et al. | Beyond the insulin pump: unraveling diabetes tech dependency | |
| Sabri et al. | Artificial Pancreas Control Algorithms Using the Hovorka Equations for Personalized Insulin Delivery in Children with T1DM | |
| AU2022382724A1 (en) | Autonomous medicament dose trimming | |
| CN119649988A (zh) | 基于趋势的胰岛素剂量调整 | |
| SHOUNG et al. | Type 1 diabetes | |
| Moore | Basic insulin pump management | |
| CH719908A2 (de) | Ein smartes Injektionssystem. |